Adverse findings in non-clinical safety/toxicity testing continue to be a major reason for failure and/or complexity in drug projects. Since primary target-related toxicity plays a

Charlotte was Platelet Services’ first official employee and joined the company in 2020 following her studies in Manchester. Her appointment was supported by a grant

Paul Cato had the pleasure of attending the Platelet Society Summer School last week on behalf of Platelet Services, which took place on the beautiful

Wendy Tomlinson is Chief Scientific Officer at Platelet Services. In this blog she talks about her career and how it is possible to pursue a

Unwanted effects of drug compounds on platelet function can include a risk of increased bleeding and thrombotic events, depending on whether inhibition or enhancement of

Tyrosine kinase inhibitors (TKIs) are widely used as a targeted strategy for cancer treatment. However, due to their broad kinase target spectrum, most TKIs inevitably